QUIAPEG PHARMAC.H. O.N.
QUIAPEG PHARMAC.H. O.N.
Share · SE0020678159 · A3EJG7 (XSTO)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 52,93 %
Shares Float 1,39 B
Shares Outstanding 2,62 B
Company Profile for QUIAPEG PHARMAC.H. O.N. Share
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
AI Analysis of QUIAPEG PHARMAC.H. O.N.
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of QUIAPEG PHARMAC.H. O.N.
No AI threads available for this company yet.

Company Data

Name QUIAPEG PHARMAC.H. O.N.
Company Quia Pharma AB (publ)
Website https://www.quiapeg.com
Primary Exchange XSTO Frankfurt
WKN A3EJG7
ISIN SE0020678159
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Marcus Bosson
Country Sweden
Currency EUR
Employees 0,0 T
Address Uppsala Business Park, 754 50 Uppsala
IPO Date 2005-06-21

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB QUIA.ST
Frankfurt 99B0.F
More Shares
Investors who hold QUIAPEG PHARMAC.H. O.N. also have the following shares in their portfolio:
ART19/29 MTN
ART19/29 MTN Bond
CHINA TONTINE WIN.
CHINA TONTINE WIN. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026